2015
DOI: 10.2147/ndt.s74861
|View full text |Cite
|
Sign up to set email alerts
|

Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients

Abstract: ObjectivesWe investigated the clinical benefits of bright light therapy (BLT) as an adjunct treatment to ongoing psychopharmacotherapy, both in unipolar and bipolar difficult-to-treat depressed (DTD) outpatients.MethodsIn an open-label study, 31 depressed outpatients (16 unipolar and 15 bipolar) were included to undergo 3 weeks of BLT. Twenty-five completed the treatment and 5-week follow-up.Main outcome measuresClinical outcomes were evaluated by the Hamilton Depression Rating Scale (HDRS). The Snaith–Hamilto… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 47 publications
0
2
0
Order By: Relevance
“…Third, the enrollment of participants with mild depression (HAMD-17 ≥ 13) who were more likely to spontaneously remit might contribute to nontreatment effects. Nonetheless, consistent with other trials [7,[50][51][52], add-on therapy was administered to patients including those with mild depression, implying partial response to antidepressants. Fourth, the majority of our participants had already taken benzodiazepines and Z-drugs for anxiety and sleep symptoms.…”
Section: Discussionsupporting
confidence: 54%
“…Third, the enrollment of participants with mild depression (HAMD-17 ≥ 13) who were more likely to spontaneously remit might contribute to nontreatment effects. Nonetheless, consistent with other trials [7,[50][51][52], add-on therapy was administered to patients including those with mild depression, implying partial response to antidepressants. Fourth, the majority of our participants had already taken benzodiazepines and Z-drugs for anxiety and sleep symptoms.…”
Section: Discussionsupporting
confidence: 54%
“…Many different factors, both individual and environment-related, have been recognized as triggers for the development of new episodes and the worsening of residual inter-episode symptoms. Among these factors, seasonality (41), the dysregulation of circadian rhythms (42), as well as abnormalities in the biological response to sunlight (43,44) and moon cycle (45), have been demonstrated to play a significant role. Therefore, climate and weather sensitivity would be expected to be related to the course of the illness as well.…”
Section: Discussionmentioning
confidence: 99%
“…Even if light treatment is reported as the treatment of choice for SAD, it may as well have a positive impact for non-seasonal forms of depression and other psychiatric conditions including bipolar disorder [ 135 ], depression in elderly subjects [ 136 , 137 , 138 ], depression in Parkinson’s disease [ 139 ], ante-/postpartum depression [ 140 ], and depression in adolescent patients [ 141 ]. A selection of the most relevant studies referring to this is offered in Table S2 in Supplementary Materials [ 97 , 105 , 135 , 142 , 143 , 144 , 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 , 154 , 155 , 156 , 157 , 158 , 159 , 160 , 161 , 162 ].…”
Section: Effects Of Light On Well-being Functioning and Mental Hementioning
confidence: 99%